Jawad Jilani, DO
Gastroenterology · N Las Vegas, NVNPI 1477870285
Payments from drug & device makers
What this record shows
This record is dominated by food and beverage: $2,941 of the $3,453 with a category attached, or 85.2%. It is spread thinly across 26 manufacturers, the largest accounting for just 20.9% — the pattern of someone who eats at a lot of different presentations. Reporting peaked in 2024 at $1,228 and has fallen 71.3% since, to $352 in 2025. That places this record below the midpoint for gastroenterology clinicians in NV, where the typical reported total is $3,212.
Across 140 payments — averaging $24.67 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Johnson & Johnson$720
- Boston Scientific$619
- AbbVie$330
- Salix Pharmaceuticals, A Division Of Bausch Health US, LLC$315
- Gilead$179
- Phathom Pharmaceuticals, Inc.$175
- plus $1K from 20 others
What the payments were for
- Travel & lodging$38511%
- Food & beverage$2,94185%
- Education$1274%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Johnson & Johnson | 40 | $720 |
| Boston Scientific | 5 | $619 |
| AbbVie | 20 | $330 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 22 | $315 |
| Gilead | 6 | $179 |
| Phathom Pharmaceuticals, Inc. | 3 | $175 |
| Enterra Medical, Inc. | 1 | $166 |
| Sanofi | 11 | $159 |
| Angiodynamics, Inc. | 1 | $117 |
| Olympus America Inc. | 1 | $115 |
| Organon | 3 | $64 |
| Takeda Pharmaceuticals U.S.A., Inc. | 4 | $63 |
| QOL Medical, LLC | 4 | $62 |
| Redhill Biopharma Inc. | 4 | $60 |
| Ironwood Pharmaceuticals, Inc | 3 | $59 |
| Ardelyx, Inc. | 2 | $42 |
| Madrigal Pharmaceuticals | 1 | $40 |
| Alnylam Pharmaceuticals Inc. | 1 | $27 |
| Orphalan Inc | 1 | $21 |
| Braintree Laboratories, Inc. | 1 | $21 |
| Ferring Pharmaceuticals Inc. | 1 | $20 |
| Bayer | 1 | $18 |
| Intra-sana Laboratories | 1 | $18 |
| Merck | 1 | $17 |
| Mallinckrodt Hospital Products Inc. | 1 | $15 |
| Nestle Healthcare Nutrition Inc. | 1 | $12 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- EXALT Model D$575
- VOQUEZNA$121
- AlphaVac$117
- EndoClot PHS$115
How this compares
$3,453 in reported general payments places this provider in the 50th percentile of 103 gastroenterology providers in Nevada.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| CreonLipase/Protease/Amylase | 14 | $39,079 |
| LinzessLinaclotide | 25 | $23,605 |
| ClenpiqSod Picosulf/Mag Ox/Citric Ac | 113 | $19,552 |
| SutabSod Sulf/Pot Chloride/Mag Sulf | 15 | $2,456 |
| Gavilyte-CPeg3350/Sod Sulf,bicarb,cl/Kcl | 82 | $1,315 |
| Pantoprazole Sodium | 195 | $1,195 |
| Gavilyte-GPeg3350/Sod Sulf,bicarb,cl/Kcl | 69 | $839 |
| Sod Sulf-Potass Sulf-Mag SulfSodium, Potassium,mag Sulfates | 12 | $743 |
| Omeprazole | 55 | $665 |
| Sucralfate | 45 | $441 |
| Clarithromycin | 13 | $437 |
| Peg-3350 And ElectrolytesPeg3350/Sod Sulf,bicarb,cl/Kcl | 21 | $379 |
| Dicyclomine Hcl | 18 | $309 |
| Famotidine | 39 | $297 |
| Metronidazole | 14 | $153 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| AbbVieCreon, Linzess | $330 | $62,68439 claims |
| Ferring Pharmaceuticals Inc.Clenpiq | $20 | $19,552113 claims |
| Braintree Laboratories, Inc.Sutab | $21 | $2,45615 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 50th percentile of 103 gastroenterology providers in Nevada.
Other gastroenterology in N Las Vegas
- George TanN Las Vegas$5K
- Shahid WahidN Las Vegas$3K
- Christian StoneLas Vegas$1.1M
- Rajat SoodHenderson$258K
- Yasser SaloumNorth Las Vegas$49K
- James HanLas Vegas$47K
- Filippo CremoniniLas Vegas$36K
- Vijay JayaramanLas Vegas$28K
- Gary ChenLas Vegas$27K
- David ShihLas Vegas$26K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.